Skip to main content
Acta Crystallographica Section E: Structure Reports Online logoLink to Acta Crystallographica Section E: Structure Reports Online
. 2014 Nov 5;70(Pt 12):456–461. doi: 10.1107/S1600536814023769

Crystal structures of 2-meth­oxy­isoindoline-1,3-dione, 1,3-dioxoisoindolin-2-yl methyl carbonate and 1,3-dioxo-2,3-di­hydro-1H-benzo[de]isoquinolin-2-yl methyl carbonate: three anti­convulsant compounds

Fortune Ezemobi a, Henry North b, Kenneth R Scott c, Anthohy K Wutoh c, Ray J Butcher d,*
PMCID: PMC4257384  PMID: 25552964

In three potentially anti­convulsant compounds, of which two are isoindoline derivatives and one an iso­quinoline derivative, the central moiety is planar. In the crystals of all three compounds, there are C—H⋯O hydrogen bonds present linking the mol­ecules into two-dimensional slabs for the isoindoline derivatives, and into a three-dimensional framework for the iso­quinoline derivative.

Keywords: crystal structure, anti­convulsant, isoindoline, iso­quinoline, indoline

Abstract

The title compounds, C9H7NO3, (1), C10H7NO5, (2), and C14H9NO5, (3), are three potentially anti­convulsant compounds. Compounds (1) and (2) are isoindoline derivatives and (3) is an iso­quinoline derivative. Compounds (2) and (3) crystallize with two independent mol­ecules (A and B) in their asymmetric units. In all three cases, the isoindoline and benzoiso­quinoline moieties are planar [r.m.s. deviations are 0.021 Å for (1), 0.04 and 0.018 Å for (2), and 0.033 and 0.041 Å for (3)]. The substituents attached to the N atom are almost perpendicular to the mean planes of the heterocycles, with dihedral angles of 89.7 (3)° for the N—O—Cmeth­yl group in (1), 71.01 (4) and 80.00 (4)° for the N—O—C(=O)O—Cmeth­yl groups in (2), and 75.62 (14) and 74.13 (4)° for the same groups in (3). In the crystal of (1), there are unusual inter­molecular C=O⋯C contacts of 2.794 (1) and 2.873 (1) Å present in mol­ecules A and B, respectively. There are also C—H⋯O hydrogen bonds and π–π inter­actions [inter-centroid distance = 3.407 (3) Å] present, forming slabs lying parallel to (001). In the crystal of (2), the A and B mol­ecules are linked by C—H⋯O hydrogen bonds, forming slabs parallel to (10-1), which are in turn linked via a number of π–π inter­actions [the most significant centroid–centroid distances are 3.4202 (7) and 3.5445 (7) Å], forming a three-dimensional structure. In the crystal of (3), the A and B mol­ecules are linked via C—H⋯O hydrogen bonds, forming a three-dimensional structure, which is consolidated by π–π inter­actions [the most significant inter-centroid distances are 3.575 (3) and 3.578 (3) Å].

Chemical context  

Traumatic brain injury (TBI) is a neurological disorder that is defined as damage to the brain resulting from external mechanical force, including accelerating, decelerating and rotating forces (Langlois et al., 2003, 2005; Ashman et al., 2006; Coronado et al., 2011). TBI also exacerbates seizure severity in individuals with pre-existing epilepsy (Ferraro et al., 1999), being one example of the process of epileptogenesis (Christensen et al., 2009). In this context, it has been demonstrated that early lesions in the central nervous system (CNS) alter the transport dynamic of the blood–brain barrier (BBB) and deteriorate the balance of the inhibitory and excitatory neurotransmitter system (Scantlebury et al., 2005]. This neuronal dysfunction predisposes to subsequent development of spontaneous recurrent seizures in the presence of prior subtle brain malformation (Love, 2005].graphic file with name e-70-00456-scheme1.jpg

TBI is the major cause of death in young individuals (14–24 years) from industrialized countries, with head injuries accounting for 25–33% of all trauma-related deaths (Abdul-Muneer et al., 2014). Disorders like memory loss, depression and seizures are some of the side effects to TBI. TBI affects people over 75 years of age because of falls and of 17–25 years of age because of accidents (Langlois et al., 2003, 2005; Ashman et al., 2006; Coronado et al., 2011). At present, there are no effective treatments available for TBI and there is thus a critical need to develop novel and effective strategies to alter the disease course. As indicated above, this health condition is quite similar to epilepsy in some instances and thus our earlier work (Alexander et al., 2013; Jackson et al., 2012; Edafiogho et al., 2007) on developing anti­convulsant compounds for the treatment of epilepsy is relevant.

Our research on pharmacologically active compounds is a multi-pronged approach, which involves synthesis, chemical characterization, computer modeling, pharmacological evaluation, and structure determination (North et al., 2012; Gibson et al., 2009). From this comprehensive approach, structure–activity correlations can be made to improve the existing pharmacologically active compounds. From our studies, we identified three imido­oxy derivatives as potential drug candidates for TBI that underwent anti­convulsant evaluation to test their ability to inhibit the onset of seizures in the in vivo MES, scPTZ test models. The MES (maximal electroshock seizure evaluation) test presented activity in animals in phase 1 testing.

2-Meth­oxy­isoindoline-1,3-dione, (1), studied by X-ray techniques, was inactive in MES and scPTZ in mice, but showed MES protection in rat studies at 50 mg kg−1 at 4 h and also protected 1/4 mice at three different time inter­vals (0.50, 1 and 2 h) in the 6 Hz test (Jackson, 2009). For scPTZ studies, the compound was Class III (no activity at 300 mg kg−1). The compound is a dual MES/6Hz active compound. Compounds (2) and (3) showed similar activity.

The title compounds, containing either an isoindoline-1,3-dione moiety, (1) (Fig. 1) and (2) (Fig. 2), or an iso­quinoline-1,3-dione moiety, (3) (Fig. 3), have been studied extensively for their anti­convulsant effects with promising results. Herein, we report on the crystal structures of these new structurally related compounds.

Figure 1.

Figure 1

The mol­ecular structure of compound (1), with atom labelling. Displacement ellipsoids are drawn at the 30% probability level.

Figure 2.

Figure 2

The mol­ecular structures of the two independent mol­ecules (A and B) of compound (2), with atom labelling. Displacement ellipsoids are drawn at the 30% probability level. The C—H⋯O hydrogen bond is shown as a dashed line (see Table 2 for details).

Figure 3.

Figure 3

The mol­ecular structures of the two independent mol­ecules (A and B) of compound (3), with atom labelling. Displacement ellipsoids are drawn at the 30% probability level. The C—H⋯O hydrogen bond is shown as a dashed line (see Table 3 for details).

Structural commentary  

In compound (1), the isoindoline ring is planar [r.m.s. deviation = 0.017 (4) Å]. The meth­oxy O atom, O3, deviates from this plane by 0.176 (6) Å while the methyl C atom, C9, is out of the plane by 1.105 (9) Å. The meth­oxy substituent is oriented almost perpendicular to the indoline ring with the dihedral angle between the mean planes of the indoline ring and the meth­oxy substituent being 89.7 (3)°.

In compound (2), there are two mol­ecules (A and B) in the asymmetric unit. The isoindoline ring is planar [r.m.s. deviation = 0.0327 (9) for A and 0.0147 (9) Å for B] with the dione O atoms significantly out of the plane for mol­ecule A but not for mol­ecule B [0.172 (1) and 0.123 (1) Å for atoms O1 and O2, respectively, in A but by only 0.013 (1) and 0.002 (1) Å, respectively, in B]. The carbonato moiety is planar in both mol­ecules [r.m.s. deviations of 0.0066 (2) and 0.0027 (5) Å for A and B, respectively] and makes dihedral angles of 71.50 (3) and 80.03 (4)° with the benzoiso­quinoline ring in A and B, respectively, indicating that these substituents are oriented almost perpendicular to the benzoiso­quinoline ring system.

In compound (3), there are also two mol­ecules (A and B) in the asymmetric unit. In both mol­ecules, the benzoiso­quinoline ring systems are planar (r.m.s. deviations for A and B = 0.033 and 0.015 Å, respectively). The meth­oxy O atom deviates from this plane by 0.126 (1) for atom O5A in A and 0.156 (1) Å for atom O5B in B. The methyl carbonate moieties are planar [r.m.s. deviations of 0.007 (1) and 0.003 (1) Å for A and B, respectively] and these substituents are oriented almost perpendicular to the iso­quinoline rings, making dihedral angles of 71.50 (3) and 80.04 (4)° for A and B, respectively. As in (2), these dihedral angles are significantly smaller than that found for (1).

Supra­molecular features  

In the crystal of (1), there are C—H⋯O hydrogen bonds (Fig. 4 and Table 1) and π–π inter­actions present, forming slabs lying parallel to (001) [Cg1⋯Cg2i,ii = 3.407 (3) Å; Cg1 and Cg2 are the centroids of rings N1/C1/C2/C7/C8 and C2–C7, respectively; symmetry codes: (i) x − 1, y, z; (ii) x + 1, y, z].

Figure 4.

Figure 4

A view along the a axis of the crystal packing of compound (1), showing the formation of the three-dimensional array by an extensive network of C—H⋯O hydrogen bonds (shown as dashed lines; see Table 1 for details).

Table 1. Hydrogen-bond geometry (, ) for (1) .

DHA DH HA D A DHA
C4H4AO2i 0.95 2.38 3.190(4) 143
C9H9AO1ii 0.98 2.54 3.428(7) 151
C9H9BO1iii 0.98 2.53 3.260(8) 131

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic.

In the crystal of (2), the A and B mol­ecules are linked by C—H⋯O hydrogen bonds (Fig. 5 and Table 2), forming slabs parallel to (10Inline graphic). The slabs are in turn linked via π–π inter­actions, forming a three-dimensional structure with centroid–centroid distances of 3.4202 (7) for Cg1⋯Cg5ii and 3.5445 (7) Å for Cg2⋯Cg4ii [Cg1, Cg2, Cg4 and Cg5 are the centroids of rings N1A/C1A/C2A/C7A/C8A, C2A–C7A, N1B/C1B/C2B/C7B/C8B and C2B–C7B, respectively; symmetry code: (ii) x + 1, y, z − 1].

Figure 5.

Figure 5

A view along the a axis of the crystal packing of compound (2), showing the three-dimensional array formed by an extensive network of C—H⋯O hydrogen bonds (dashed lines; see Table 2 for details).

Table 2. Hydrogen-bond geometry (, ) for (2) .

DHA DH HA D A DHA
C5AH5AAO3B i 0.95 2.54 3.3341(15) 141
C6AH6AAO4A ii 0.95 2.51 3.4091(15) 158
C3BH3BAO2A iii 0.95 2.59 3.2281(14) 125
C6BH6BAO3A iv 0.95 2.55 3.3086(14) 137
C10BH10FO2B v 0.98 2.57 3.4956(16) 157

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic; (iv) Inline graphic; (v) Inline graphic.

In the crystal of (3), the A and B mol­ecules are linked by C—H⋯O hydrogen bonds (Fig. 6 and Table 3), forming a three-dimensional structure, which is consolidated by π–π inter­actions [Cg1⋯Cg3iii = 3.578 (3), Cg2⋯Cg3iii = 3.575 (3) Å and Cg9⋯Cg10iv; Cg1, Cg2, Cg3, Cg9 and Cg10 are the centroids of rings N1A/C1A–C5A, C2A/C3A/C6A–C9A, C3A/C4A/C9A–C12A, C2B/C3B/C6B–C9B and C3B/C4B/C9B–C12B, respectively; symmetry codes: (iii) x, −y + Inline graphic, z − Inline graphic; (iv) x, −y + Inline graphic, z + Inline graphic].

Figure 6.

Figure 6

For mol­ecule A in compound (2), perpendicular inter­actions between atoms O1A and C9A (shown as dashed lines) link the mol­ecules into inversion dimers [symmetry code: (A) − x + 1, − y + 2, −z].

Table 3. Hydrogen-bond geometry (, ) for (3) .

DHA DH HA D A DHA
C6AH6AAO4A i 0.95 2.51 3.159(5) 125
C7BH7BAO2B ii 0.95 2.51 3.229(5) 133
C10BH10BO5B ii 0.95 2.60 3.428(5) 146
C11BH11BO1A iii 0.95 2.48 3.270(6) 141
C14AH14AO1B iv 0.98 2.51 3.481(5) 169
C14BH14EO4A iv 0.98 2.51 3.306(6) 138

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic; (iv) Inline graphic.

Inter­estingly, in the crystal of (2) one of the two dione moieties for each mol­ecule (O1A and O1B) has a short inter­molecular inter­actions with the central C atom of the carbonato group [O1A⋯C9A = 2.794 (1), O1B⋯C9B = 2.873 (1) Å], which is perpendicular to the carbonato plane indicating that both atoms, C9A and C9B, must have significant positive character. These inter­actions link the mol­ecules into dimers as shown in Figs. 6 and 7, respectively. This is also noticed to a lesser extent in (3) (Fig. 8) for mol­ecule A (but not for mol­ecule B), where a longer inter­molecular inter­action of 3.060 (3) Å is observed between atoms O2A and C13A, resulting in weakly associated dimers similar to that seen in the case of (2).

Figure 7.

Figure 7

For mol­ecule B in compound (2), perpendicular inter­actions between atoms O1B and C9B (shown as dashed lines) link the mol­ecules into inversion dimers [symmetry code: (A) −x, −y + 1, −z − 1].

Figure 8.

Figure 8

A view along the a axis of the crystal packing of compound (3), showing the formation of the three-dimensional array by an extensive network of C—H⋯O hydrogen bonds (dashed lines; see Table 3 for details).

Database survey  

A search of the Cambridge Structural Database (Version 5.35; Groom & Allen, 2014) for the indoline skeleton gave 26 hits. In all cases, the geometrical parameters of the indoline skeleton are similar to those observed in compounds (1) and (2). In the case of the iso­quinoline structure, there are only two structures containing the planar iso­quinoline moiety with similar geometrical parameters to the present structure, (3).

Synthesis and crystallization  

Compound (1):

To a freshly prepared solution of sodium (2.3 g, 0.10 mol) in absolute ethanol (60 ml) was added a solution of N-hy­droxy­phthalimide (16.3 g, 0.10 mol) in absolute ethanol (350 ml), and the red reaction mixture was stirred at room temperature for 30 min. The brick-red precipitate was collected, washed with water, and dried in the oven at 373 K for 30 min to give 17.45 g (95%) of sodium phthalimide oxide as brick-red crystals; m.p. > 573 K. To the solution of sodium phthalimide oxide (0.92 g, 5 mmol) in water (15 ml) was added acetone (10 ml), followed by a solution of bromo­methane (0.66 g, 7 mmol). The reaction mixture was stirred at room temperature for 16 h, during which the red color disappeared. On standing at room temperature for 48 h, the product solidified in the aqueous mixture and was collected. Recrystallization from 2-propanol gave 0.72 g (78%) of compound (1) as plate-like colorless crystals: m.p. 395–397 K; 1H NMR (CDC13) δ 3.36 (s, 3H, J = 6 Hz, OCH3), 5.52, s, 1 H,CH, 7.87 (m, 4 H, phthalimido ring).

Compound (2):

To a solution of sodium phthalimide oxide (0.92 g, 5 mmol) in water (15 ml) was added acetone (10 ml), followed by a solution of bromo­(meth­oxy)methanone (0.97 g, 7 mmol). The reaction mixture was stirred at room temperature for 16 h, during which the red color disappeared. On standing at room temperature for 48 h, the product solidified in the aqueous mixture and was collected. Recrystallization from ethanol gave 0.82 g (74%) of compound (2) as colorless crystals: m.p. 410–411 K; 1H NMR (CDC13) δ 3.8 (s, 3H,OCH3), 7.86 (m, 4H, phthalimido ring).

Compound (3):

To a solution of sodium naphthalimide oxide, (1.18 g, 5 mmol), in water (50 ml), was added bromo­(meth­oxy)methanone (1.25g, 7 mmol) in acetone (10 ml). The red reaction mixture was stirred at room temperature. The red color disappeared within 5 min and the reaction mixture was filled with a white precipitate. After standing for 4 h, the white precipitate was collected, washed with water, and recrystallized from ethanol to give 1.46 g (89%) of compound (3) as colorless crystals: m.p. 483–485 K; 1H NMR (CDCl3) δ 3.79 (s, 3H, OCH3), 5.66 (s, 1H, CH), 7.65–8.50 (m, 6 H, naphthal­imido ring).

Refinement  

Crystal data, data collection and structure refinement details for (1), (2) and (3) are summarized in Table 4. For all three compounds, the H atoms were positioned geometrically and refined as riding: C—H = 0.93–0.99 Å with Uiso(H) = 1.5U eq(C) for methyl H atoms and = 1.2Ueq(C) for other H atoms.

Table 4. Experimental details.

  (1) (2) (3)
Crystal data
Chemical formula C9H7NO3 C10H7NO5 C14H9NO5
M r 177.16 221.17 271.22
Crystal system, space group Orthorhombic, P212121 Triclinic, P Inline graphic Monoclinic, P21/c
Temperature (K) 123 123 123
a, b, c () 4.2987(4), 7.0243(10), 27.587(4) 7.0363(4), 11.0082(5), 12.4239(6) 16.512(3), 18.579(3), 7.6156(13)
, , () 90, 90, 90 98.884(4), 96.159(4), 93.009(4) 90, 99.434(17), 90
V (3) 832.98(19) 942.95(8) 2304.6(7)
Z 4 4 8
Radiation type Mo K Cu K Mo K
(mm1) 0.11 1.10 0.12
Crystal size (mm) 0.66 0.23 0.04 0.35 0.25 0.08 0.44 0.12 0.07
 
Data collection
Diffractometer Agilent Xcalibur (Ruby, Gemini) SuperNova (Dual, Cu at zero, Atlas) Agilent Xcalibur (Ruby, Gemini)
Absorption correction Analytical (CrysAlis PRO; Agilent, 2012) Multi-scan (CrysAlis PRO; Agilent, 2012) Analytical (CrysAlis PRO; Agilent, 2012)
T min, T max 0.946, 0.996 0.807, 1.000 0.995, 0.999
No. of measured, independent and observed [I > 2(I)] reflections 5145, 2259, 1989 6437, 3803, 3516 9949, 4156, 1898
R int 0.087 0.018 0.091
(sin /)max (1) 0.727 0.631 0.600
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.099, 0.229, 1.13 0.033, 0.089, 1.06 0.080, 0.224, 1.00
No. of reflections 2259 3803 4156
No. of parameters 119 291 363
H-atom treatment H-atom parameters constrained H-atom parameters constrained H-atom parameters constrained
max, min (e 3) 0.50, 0.34 0.29, 0.21 0.33, 0.39

Computer programs: CrysAlis PRO (Agilent, 2012), SUPERFLIP (Palatinus Chapuis, 2007), SHELXS2013, SHELXL2013 and SHELXTL (Sheldrick, 2008) and SUPERFLIP (Palatinus et al. 2007).

Supplementary Material

Crystal structure: contains datablock(s) 1, 2, 3. DOI: 10.1107/S1600536814023769/su2795sup1.cif

e-70-00456-sup1.cif (739.5KB, cif)

Structure factors: contains datablock(s) 1. DOI: 10.1107/S1600536814023769/su27951sup2.hkl

e-70-00456-1sup2.hkl (78.3KB, hkl)

Structure factors: contains datablock(s) 2. DOI: 10.1107/S1600536814023769/su27952sup3.hkl

e-70-00456-2sup3.hkl (208.7KB, hkl)

Structure factors: contains datablock(s) 3. DOI: 10.1107/S1600536814023769/su27953sup4.hkl

e-70-00456-3sup4.hkl (228KB, hkl)

Supporting information file. DOI: 10.1107/S1600536814023769/su27951sup5.cml

Supporting information file. DOI: 10.1107/S1600536814023769/su27952sup6.cml

Supporting information file. DOI: 10.1107/S1600536814023769/su27953sup7.cml

CCDC references: 1031391, 1031392, 1031393

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

FE wishes to acknowledge Dr Ivan Edafiogho, University of Saint Joseph SOP and Professor Emeritus Kenneth R. Scott, for their generous donation of the compounds studied. The authors are indebted to Mr James P. Stables (retired), Epilepsy Branch, Division of Convulsive, Developmental and Neuromuscular Disorders, National Institute of Neurological Disorders and Stroke, for helpful discussions and initial data. The authors wish to acknowledge Drs Ivan Edafiogho and Mariano S. Alexander, for their generous assistance and support in completing this project. RJB is grateful to the NSF–MRI program (grant CHE-0619278) for funds to purchase the diffractometer and the Howard University Nanoscience Facility for access to liquid nitro­gen.

supplementary crystallographic information

Crystal data

C14H9NO5 F(000) = 1120
Mr = 271.22 Dx = 1.563 Mg m3
Monoclinic, P21/c Mo Kα radiation, λ = 0.71073 Å
a = 16.512 (3) Å Cell parameters from 1261 reflections
b = 18.579 (3) Å θ = 3.4–26.9°
c = 7.6156 (13) Å µ = 0.12 mm1
β = 99.434 (17)° T = 123 K
V = 2304.6 (7) Å3 Needle, colorless
Z = 8 0.44 × 0.12 × 0.07 mm

Data collection

Agilent Xcalibur (Ruby, Gemini) diffractometer 4156 independent reflections
Radiation source: Enhance (Mo) X-ray Source 1898 reflections with I > 2σ(I)
Detector resolution: 10.5081 pixels mm-1 Rint = 0.091
ω scans θmax = 25.3°, θmin = 3.3°
Absorption correction: analytical (CrysAlis PRO; Agilent, 2012) h = −15→19
Tmin = 0.995, Tmax = 0.999 k = −22→21
9949 measured reflections l = −9→9

Refinement

Refinement on F2 0 restraints
Least-squares matrix: full Hydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.080 H-atom parameters constrained
wR(F2) = 0.224 w = 1/[σ2(Fo2) + (0.0796P)2] where P = (Fo2 + 2Fc2)/3
S = 1.00 (Δ/σ)max < 0.001
4156 reflections Δρmax = 0.33 e Å3
363 parameters Δρmin = −0.39 e Å3

Special details

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
O1A 0.3491 (2) 0.31532 (15) 0.1257 (5) 0.0428 (9)
O2A 0.5630 (2) 0.44236 (15) 0.4206 (4) 0.0441 (9)
O3A 0.4152 (2) 0.43894 (14) 0.2299 (4) 0.0384 (9)
O4A 0.3270 (2) 0.41710 (15) 0.4258 (4) 0.0413 (9)
O5A 0.31114 (19) 0.50794 (14) 0.2257 (4) 0.0367 (8)
N1A 0.4539 (3) 0.37502 (17) 0.2925 (5) 0.0375 (10)
C1A 0.4144 (3) 0.3116 (2) 0.2245 (7) 0.0370 (12)
C2A 0.4578 (3) 0.2448 (2) 0.2868 (6) 0.0334 (11)
C3A 0.5339 (3) 0.2484 (2) 0.4016 (6) 0.0335 (11)
C4A 0.5716 (3) 0.3145 (2) 0.4574 (6) 0.0359 (12)
C5A 0.5329 (3) 0.3829 (2) 0.3934 (6) 0.0344 (12)
C6A 0.4237 (3) 0.1799 (2) 0.2309 (6) 0.0361 (12)
H6AA 0.3722 0.1785 0.1543 0.043*
C7A 0.4646 (3) 0.1149 (2) 0.2864 (7) 0.0400 (13)
H7AA 0.4415 0.0700 0.2451 0.048*
C8A 0.5375 (3) 0.1174 (2) 0.3996 (7) 0.0369 (12)
H8AA 0.5642 0.0735 0.4376 0.044*
C9A 0.5748 (3) 0.1828 (2) 0.4622 (7) 0.0365 (12)
C10A 0.6507 (3) 0.1873 (2) 0.5762 (7) 0.0411 (13)
H10A 0.6786 0.1443 0.6171 0.049*
C11A 0.6852 (3) 0.2519 (2) 0.6293 (6) 0.0385 (12)
H11A 0.7365 0.2534 0.7069 0.046*
C12A 0.6457 (3) 0.3158 (2) 0.5705 (6) 0.0378 (12)
H12A 0.6701 0.3606 0.6087 0.045*
C13A 0.3473 (3) 0.4514 (2) 0.3079 (7) 0.0354 (12)
C14A 0.2353 (3) 0.5276 (2) 0.2859 (6) 0.0427 (13)
H14A 0.2134 0.5717 0.2253 0.064*
H14B 0.2459 0.5358 0.4147 0.064*
H14C 0.1953 0.4886 0.2583 0.064*
O1B 0.1669 (2) 0.82517 (15) 0.5198 (4) 0.0392 (8)
O2B −0.0410 (2) 0.95254 (15) 0.2005 (4) 0.0468 (10)
O3B 0.1021 (2) 0.94818 (14) 0.4052 (4) 0.0384 (9)
O4B 0.1866 (2) 0.92546 (16) 0.2003 (4) 0.0434 (9)
O5B 0.1998 (2) 1.02184 (14) 0.3847 (4) 0.0392 (9)
N1B 0.0622 (3) 0.88420 (17) 0.3479 (5) 0.0363 (10)
C1B 0.1017 (3) 0.8213 (2) 0.4202 (7) 0.0359 (12)
C2B 0.0594 (3) 0.7545 (2) 0.3564 (6) 0.0325 (11)
C3B −0.0186 (3) 0.7576 (2) 0.2461 (6) 0.0358 (12)
C4B −0.0567 (3) 0.8244 (2) 0.1926 (6) 0.0349 (12)
C5B −0.0156 (3) 0.8933 (2) 0.2436 (7) 0.0376 (12)
C6B 0.0945 (3) 0.6896 (2) 0.4060 (6) 0.0363 (12)
H6BA 0.1462 0.6879 0.4820 0.044*
C7B 0.0547 (3) 0.6251 (2) 0.3450 (7) 0.0392 (13)
H7BA 0.0803 0.5802 0.3780 0.047*
C8B −0.0194 (3) 0.6266 (2) 0.2403 (7) 0.0400 (13)
H8BA −0.0454 0.5825 0.2016 0.048*
C9B −0.0595 (3) 0.6923 (2) 0.1864 (6) 0.0356 (12)
C10B −0.1376 (3) 0.6966 (2) 0.0811 (7) 0.0432 (13)
H10B −0.1652 0.6535 0.0395 0.052*
C11B −0.1745 (3) 0.7611 (2) 0.0371 (7) 0.0459 (13)
H11B −0.2282 0.7626 −0.0307 0.055*
C12B −0.1335 (3) 0.8257 (2) 0.0917 (7) 0.0415 (13)
H12B −0.1592 0.8705 0.0585 0.050*
C13B 0.1661 (3) 0.9614 (2) 0.3143 (7) 0.0365 (12)
C14B 0.2722 (3) 1.0450 (2) 0.3140 (7) 0.0454 (14)
H14D 0.2953 1.0880 0.3779 0.068*
H14E 0.2569 1.0562 0.1871 0.068*
H14F 0.3132 1.0063 0.3292 0.068*

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
O1A 0.037 (2) 0.0392 (18) 0.047 (2) 0.0021 (16) −0.0087 (18) −0.0011 (15)
O2A 0.044 (2) 0.0267 (16) 0.058 (2) −0.0019 (16) −0.0013 (18) −0.0040 (15)
O3A 0.037 (2) 0.0299 (16) 0.046 (2) 0.0043 (15) −0.0004 (17) 0.0045 (14)
O4A 0.048 (2) 0.0313 (16) 0.044 (2) 0.0042 (16) 0.0033 (18) 0.0056 (16)
O5A 0.039 (2) 0.0245 (15) 0.045 (2) 0.0049 (15) 0.0022 (17) 0.0062 (14)
N1A 0.038 (3) 0.0219 (19) 0.049 (3) 0.0043 (18) −0.003 (2) −0.0012 (17)
C1A 0.041 (4) 0.029 (2) 0.040 (3) 0.001 (2) 0.003 (3) 0.000 (2)
C2A 0.034 (3) 0.026 (2) 0.040 (3) −0.003 (2) 0.005 (2) 0.001 (2)
C3A 0.036 (3) 0.027 (2) 0.037 (3) 0.002 (2) 0.005 (2) 0.003 (2)
C4A 0.036 (3) 0.032 (2) 0.038 (3) −0.002 (2) 0.000 (2) −0.002 (2)
C5A 0.038 (3) 0.031 (3) 0.033 (3) −0.003 (2) 0.004 (2) 0.000 (2)
C6A 0.036 (3) 0.035 (3) 0.037 (3) −0.006 (2) 0.005 (2) −0.001 (2)
C7A 0.043 (4) 0.029 (2) 0.048 (3) −0.002 (2) 0.010 (3) −0.006 (2)
C8A 0.043 (4) 0.029 (2) 0.038 (3) 0.004 (2) 0.006 (3) 0.002 (2)
C9A 0.037 (3) 0.029 (2) 0.044 (3) 0.002 (2) 0.007 (3) −0.005 (2)
C10A 0.039 (3) 0.035 (3) 0.048 (4) 0.007 (2) 0.006 (3) 0.002 (2)
C11A 0.029 (3) 0.045 (3) 0.039 (3) 0.002 (2) −0.005 (2) −0.001 (2)
C12A 0.042 (3) 0.034 (2) 0.037 (3) 0.000 (2) 0.004 (3) −0.009 (2)
C13A 0.036 (3) 0.031 (2) 0.038 (3) −0.004 (2) 0.003 (3) −0.003 (2)
C14A 0.041 (3) 0.037 (3) 0.046 (3) 0.002 (2) −0.002 (3) 0.002 (2)
O1B 0.035 (2) 0.0361 (17) 0.044 (2) 0.0022 (16) −0.0005 (17) −0.0033 (15)
O2B 0.050 (3) 0.0270 (17) 0.059 (3) 0.0022 (16) −0.0037 (19) 0.0046 (15)
O3B 0.040 (2) 0.0257 (16) 0.048 (2) −0.0046 (15) 0.0019 (18) −0.0046 (14)
O4B 0.050 (2) 0.0384 (18) 0.041 (2) −0.0032 (16) 0.0047 (18) −0.0054 (16)
O5B 0.046 (2) 0.0265 (16) 0.043 (2) −0.0059 (15) 0.0031 (17) −0.0044 (14)
N1B 0.037 (3) 0.0213 (19) 0.046 (3) −0.0027 (18) −0.006 (2) −0.0020 (17)
C1B 0.033 (3) 0.036 (3) 0.037 (3) 0.005 (2) 0.002 (3) 0.001 (2)
C2B 0.035 (3) 0.027 (2) 0.035 (3) 0.001 (2) 0.002 (2) −0.007 (2)
C3B 0.040 (3) 0.030 (2) 0.038 (3) 0.001 (2) 0.005 (2) 0.003 (2)
C4B 0.033 (3) 0.032 (2) 0.038 (3) −0.004 (2) 0.001 (2) 0.000 (2)
C5B 0.040 (4) 0.032 (3) 0.041 (3) −0.001 (2) 0.006 (3) −0.002 (2)
C6B 0.039 (3) 0.031 (2) 0.039 (3) 0.001 (2) 0.008 (2) 0.003 (2)
C7B 0.047 (4) 0.025 (2) 0.046 (3) 0.002 (2) 0.010 (3) 0.003 (2)
C8B 0.040 (4) 0.030 (2) 0.050 (4) −0.004 (2) 0.006 (3) −0.002 (2)
C9B 0.037 (3) 0.036 (3) 0.032 (3) −0.005 (2) 0.003 (2) −0.002 (2)
C10B 0.041 (4) 0.037 (3) 0.049 (3) −0.009 (2) 0.000 (3) 0.005 (2)
C11B 0.042 (3) 0.048 (3) 0.045 (3) −0.006 (3) −0.001 (3) 0.001 (2)
C12B 0.040 (4) 0.037 (3) 0.046 (3) 0.001 (2) 0.002 (3) 0.006 (2)
C13B 0.036 (3) 0.030 (3) 0.042 (3) 0.002 (2) 0.000 (3) 0.007 (2)
C14B 0.044 (4) 0.037 (3) 0.055 (4) −0.010 (2) 0.007 (3) 0.001 (2)

Geometric parameters (Å, º)

O1A—C1A 1.211 (6) O1B—C1B 1.212 (5)
O2A—C5A 1.215 (5) O2B—C5B 1.204 (5)
O3A—C13A 1.371 (5) O3B—C13B 1.377 (5)
O3A—N1A 1.395 (4) O3B—N1B 1.394 (4)
O4A—C13A 1.193 (5) O4B—C13B 1.188 (5)
O5A—C13A 1.316 (5) O5B—C13B 1.326 (5)
O5A—C14A 1.449 (5) O5B—C14B 1.455 (5)
N1A—C1A 1.403 (6) N1B—C5B 1.405 (6)
N1A—C5A 1.408 (6) N1B—C1B 1.406 (6)
C1A—C2A 1.473 (6) C1B—C2B 1.468 (6)
C2A—C6A 1.370 (6) C2B—C6B 1.365 (6)
C2A—C3A 1.409 (6) C2B—C3B 1.419 (6)
C3A—C4A 1.410 (6) C3B—C4B 1.419 (6)
C3A—C9A 1.432 (6) C3B—C9B 1.427 (6)
C4A—C12A 1.377 (7) C4B—C12B 1.371 (7)
C4A—C5A 1.471 (6) C4B—C5B 1.472 (6)
C6A—C7A 1.413 (6) C6B—C7B 1.408 (6)
C6A—H6AA 0.9500 C6B—H6BA 0.9500
C7A—C8A 1.362 (7) C7B—C8B 1.347 (7)
C7A—H7AA 0.9500 C7B—H7BA 0.9500
C8A—C9A 1.410 (6) C8B—C9B 1.417 (6)
C8A—H8AA 0.9500 C8B—H8BA 0.9500
C9A—C10A 1.405 (7) C9B—C10B 1.404 (7)
C10A—C11A 1.361 (6) C10B—C11B 1.362 (6)
C10A—H10A 0.9500 C10B—H10B 0.9500
C11A—C12A 1.392 (6) C11B—C12B 1.406 (6)
C11A—H11A 0.9500 C11B—H11B 0.9500
C12A—H12A 0.9500 C12B—H12B 0.9500
C14A—H14A 0.9800 C14B—H14D 0.9800
C14A—H14B 0.9800 C14B—H14E 0.9800
C14A—H14C 0.9800 C14B—H14F 0.9800
C13A—O3A—N1A 110.9 (3) C13B—O3B—N1B 111.0 (3)
C13A—O5A—C14A 113.6 (3) C13B—O5B—C14B 114.6 (4)
O3A—N1A—C1A 115.4 (4) O3B—N1B—C5B 114.5 (3)
O3A—N1A—C5A 115.4 (3) O3B—N1B—C1B 114.9 (4)
C1A—N1A—C5A 128.4 (4) C5B—N1B—C1B 130.2 (4)
O1A—C1A—N1A 119.6 (4) O1B—C1B—N1B 120.2 (4)
O1A—C1A—C2A 125.8 (4) O1B—C1B—C2B 125.7 (4)
N1A—C1A—C2A 114.6 (5) N1B—C1B—C2B 114.0 (5)
C6A—C2A—C3A 120.9 (4) C6B—C2B—C3B 120.2 (4)
C6A—C2A—C1A 119.3 (5) C6B—C2B—C1B 119.8 (5)
C3A—C2A—C1A 119.8 (4) C3B—C2B—C1B 119.9 (4)
C2A—C3A—C4A 122.2 (4) C2B—C3B—C4B 121.4 (4)
C2A—C3A—C9A 119.0 (4) C2B—C3B—C9B 119.3 (4)
C4A—C3A—C9A 118.8 (5) C4B—C3B—C9B 119.2 (5)
C12A—C4A—C3A 120.5 (4) C12B—C4B—C3B 120.1 (4)
C12A—C4A—C5A 119.1 (4) C12B—C4B—C5B 118.5 (4)
C3A—C4A—C5A 120.4 (5) C3B—C4B—C5B 121.4 (5)
O2A—C5A—N1A 120.3 (4) O2B—C5B—N1B 120.7 (4)
O2A—C5A—C4A 125.9 (5) O2B—C5B—C4B 126.7 (5)
N1A—C5A—C4A 113.8 (4) N1B—C5B—C4B 112.5 (4)
C2A—C6A—C7A 120.5 (5) C2B—C6B—C7B 120.4 (5)
C2A—C6A—H6AA 119.7 C2B—C6B—H6BA 119.8
C7A—C6A—H6AA 119.7 C7B—C6B—H6BA 119.8
C8A—C7A—C6A 119.3 (4) C8B—C7B—C6B 120.5 (4)
C8A—C7A—H7AA 120.3 C8B—C7B—H7BA 119.8
C6A—C7A—H7AA 120.3 C6B—C7B—H7BA 119.8
C7A—C8A—C9A 122.3 (4) C7B—C8B—C9B 121.7 (4)
C7A—C8A—H8AA 118.8 C7B—C8B—H8BA 119.1
C9A—C8A—H8AA 118.8 C9B—C8B—H8BA 119.1
C10A—C9A—C8A 123.8 (4) C10B—C9B—C8B 123.8 (4)
C10A—C9A—C3A 118.3 (4) C10B—C9B—C3B 118.4 (4)
C8A—C9A—C3A 117.9 (5) C8B—C9B—C3B 117.8 (5)
C11A—C10A—C9A 121.6 (4) C11B—C10B—C9B 121.5 (5)
C11A—C10A—H10A 119.2 C11B—C10B—H10B 119.2
C9A—C10A—H10A 119.2 C9B—C10B—H10B 119.2
C10A—C11A—C12A 120.3 (5) C10B—C11B—C12B 120.2 (5)
C10A—C11A—H11A 119.9 C10B—C11B—H11B 119.9
C12A—C11A—H11A 119.9 C12B—C11B—H11B 119.9
C4A—C12A—C11A 120.5 (4) C4B—C12B—C11B 120.5 (5)
C4A—C12A—H12A 119.7 C4B—C12B—H12B 119.8
C11A—C12A—H12A 119.7 C11B—C12B—H12B 119.8
O4A—C13A—O5A 128.5 (4) O4B—C13B—O5B 128.3 (5)
O4A—C13A—O3A 126.0 (4) O4B—C13B—O3B 126.9 (4)
O5A—C13A—O3A 105.6 (4) O5B—C13B—O3B 104.7 (4)
O5A—C14A—H14A 109.5 O5B—C14B—H14D 109.5
O5A—C14A—H14B 109.5 O5B—C14B—H14E 109.5
H14A—C14A—H14B 109.5 H14D—C14B—H14E 109.5
O5A—C14A—H14C 109.5 O5B—C14B—H14F 109.5
H14A—C14A—H14C 109.5 H14D—C14B—H14F 109.5
H14B—C14A—H14C 109.5 H14E—C14B—H14F 109.5
C13A—O3A—N1A—C1A 75.2 (5) C13B—O3B—N1B—C5B −107.2 (4)
C13A—O3A—N1A—C5A −113.9 (4) C13B—O3B—N1B—C1B 79.7 (5)
O3A—N1A—C1A—O1A −3.6 (6) O3B—N1B—C1B—O1B −2.2 (6)
C5A—N1A—C1A—O1A −173.0 (5) C5B—N1B—C1B—O1B −173.9 (5)
O3A—N1A—C1A—C2A 177.8 (4) O3B—N1B—C1B—C2B −179.2 (3)
C5A—N1A—C1A—C2A 8.3 (7) C5B—N1B—C1B—C2B 9.1 (7)
O1A—C1A—C2A—C6A 0.3 (8) O1B—C1B—C2B—C6B −1.7 (8)
N1A—C1A—C2A—C6A 178.8 (4) N1B—C1B—C2B—C6B 175.1 (4)
O1A—C1A—C2A—C3A 179.8 (5) O1B—C1B—C2B—C3B 177.2 (4)
N1A—C1A—C2A—C3A −1.6 (6) N1B—C1B—C2B—C3B −6.0 (7)
C6A—C2A—C3A—C4A 178.2 (4) C6B—C2B—C3B—C4B 180.0 (4)
C1A—C2A—C3A—C4A −1.3 (7) C1B—C2B—C3B—C4B 1.1 (7)
C6A—C2A—C3A—C9A −1.1 (7) C6B—C2B—C3B—C9B −0.5 (7)
C1A—C2A—C3A—C9A 179.4 (4) C1B—C2B—C3B—C9B −179.4 (4)
C2A—C3A—C4A—C12A 179.6 (4) C2B—C3B—C4B—C12B −177.4 (4)
C9A—C3A—C4A—C12A −1.1 (7) C9B—C3B—C4B—C12B 3.1 (7)
C2A—C3A—C4A—C5A −1.3 (7) C2B—C3B—C4B—C5B 2.3 (7)
C9A—C3A—C4A—C5A 178.0 (4) C9B—C3B—C4B—C5B −177.2 (4)
O3A—N1A—C5A—O2A −0.2 (7) O3B—N1B—C5B—O2B 4.6 (6)
C1A—N1A—C5A—O2A 169.3 (4) C1B—N1B—C5B—O2B 176.3 (4)
O3A—N1A—C5A—C4A 179.8 (3) O3B—N1B—C5B—C4B −177.6 (3)
C1A—N1A—C5A—C4A −10.7 (7) C1B—N1B—C5B—C4B −5.9 (7)
C12A—C4A—C5A—O2A 5.6 (8) C12B—C4B—C5B—O2B −3.0 (8)
C3A—C4A—C5A—O2A −173.4 (5) C3B—C4B—C5B—O2B 177.3 (5)
C12A—C4A—C5A—N1A −174.3 (4) C12B—C4B—C5B—N1B 179.4 (4)
C3A—C4A—C5A—N1A 6.6 (7) C3B—C4B—C5B—N1B −0.3 (7)
C3A—C2A—C6A—C7A −0.5 (7) C3B—C2B—C6B—C7B 1.4 (7)
C1A—C2A—C6A—C7A 179.0 (4) C1B—C2B—C6B—C7B −179.7 (4)
C2A—C6A—C7A—C8A 1.5 (7) C2B—C6B—C7B—C8B −1.5 (7)
C6A—C7A—C8A—C9A −0.9 (7) C6B—C7B—C8B—C9B 0.6 (8)
C7A—C8A—C9A—C10A −178.7 (5) C7B—C8B—C9B—C10B −178.4 (5)
C7A—C8A—C9A—C3A −0.6 (7) C7B—C8B—C9B—C3B 0.3 (7)
C2A—C3A—C9A—C10A 179.8 (4) C2B—C3B—C9B—C10B 178.4 (4)
C4A—C3A—C9A—C10A 0.5 (7) C4B—C3B—C9B—C10B −2.1 (7)
C2A—C3A—C9A—C8A 1.6 (7) C2B—C3B—C9B—C8B −0.4 (7)
C4A—C3A—C9A—C8A −177.7 (4) C4B—C3B—C9B—C8B 179.2 (4)
C8A—C9A—C10A—C11A 178.2 (4) C8B—C9B—C10B—C11B 178.1 (5)
C3A—C9A—C10A—C11A 0.2 (8) C3B—C9B—C10B—C11B −0.6 (8)
C9A—C10A—C11A—C12A −0.3 (7) C9B—C10B—C11B—C12B 2.3 (8)
C3A—C4A—C12A—C11A 1.0 (8) C3B—C4B—C12B—C11B −1.4 (8)
C5A—C4A—C12A—C11A −178.0 (4) C5B—C4B—C12B—C11B 178.9 (4)
C10A—C11A—C12A—C4A −0.3 (7) C10B—C11B—C12B—C4B −1.3 (8)
C14A—O5A—C13A—O4A −2.6 (7) C14B—O5B—C13B—O4B −1.5 (7)
C14A—O5A—C13A—O3A 177.5 (3) C14B—O5B—C13B—O3B 177.3 (3)
N1A—O3A—C13A—O4A 6.8 (6) N1B—O3B—C13B—O4B 0.7 (7)
N1A—O3A—C13A—O5A −173.3 (3) N1B—O3B—C13B—O5B −178.1 (3)

Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
C6A—H6AA···O4Ai 0.95 2.51 3.159 (5) 125
C7B—H7BA···O2Bii 0.95 2.51 3.229 (5) 133
C10B—H10B···O5Bii 0.95 2.60 3.428 (5) 146
C11B—H11B···O1Aiii 0.95 2.48 3.270 (6) 141
C14A—H14A···O1Biv 0.98 2.51 3.481 (5) 169
C14B—H14E···O4Aiv 0.98 2.51 3.306 (6) 138

Symmetry codes: (i) x, −y+1/2, z−1/2; (ii) −x, y−1/2, −z+1/2; (iii) −x, −y+1, −z; (iv) x, −y+3/2, z−1/2.

References

  1. Abdul-Muneer, P. M., Namas, C. & James, H. (2014). Mol. Neurobiol. 10.1007/s12035-014-8752-3.
  2. Agilent (2012). CrysAlis PRO. Agilent Technologies, Yarnton, England.
  3. Alexander, M. S., Scott, K. R., Harkless, J., Butcher, R. J. & Jackson-Ayotunde, P. L. (2013). Bioorg. Med. Chem. 21, 3272–3279. [DOI] [PubMed]
  4. Ashman, T. A., Gordon, W. A., Cantor, J. B. & Hibbard, M. R. (2006). Mt Sinai J. Med. 73, 999–1005. [PubMed]
  5. Christensen, J., Pedersen, M. G., Pedersen, C. B., Sidenius, P., Olsen, J. & Vestergaard, M. (2009). Lancet, 373, 1105–1110. [DOI] [PubMed]
  6. Coronado, V. G., Xu, L., Basavaraju, S. V., McGuire, L. C., Wald, M. M., Faul, M. D., Guzman, B. R. & Hemphill, J. D. (2011). MMWR Surveill. Summ. 60, 1–32. [PubMed]
  7. Edafiogho, I. O., Kombian, S. B., Ananthalakshmi, K. V. V., Salama, N. N., Eddington, N. D., Wilson, T. L., Alexander, M. S., Jackson, P. L., Hanson, C. D. & Scott, K. R. (2007). J. Pharm. Sci. 96, 2509–2531. [DOI] [PubMed]
  8. Ferraro, T. N., Golden, G. T., Smith, G. G., St Jean, P., Schork, N. J., Mulholland, N., Ballas, C., Schill, J., Buono, R. J. & Berrettini, W. H. (1999). J. Neurosci. 19, 6733–6739. [DOI] [PMC free article] [PubMed]
  9. Gibson, A., Harkless, J., Alexander, M. & Scott, K. R. (2009). Bioorg. Med. Chem. 17, 5342–5346. [DOI] [PubMed]
  10. Groom, C. R. & Allen, F. H. (2014). Angew. Chem. Int. Ed. 53, 662–671. [DOI] [PubMed]
  11. Jackson, P. L. (2009). PhD thesis, Howard University, Washington, DC, USA.
  12. Jackson, P. L., Hanson, C. D., Farrell, A. K., Butcher, R. J., Stables, J. P., Eddington, N. D. & Scott, K. R. (2012). Eur. J. Med. Chem. 51, 42–51. [DOI] [PubMed]
  13. Langlois, J. A., Kegler, S. R., Butler, J. A., Gotsch, K. E., Johnson, R. L., Reichard, A. A., Webb, K. W., Coronado, V. G., Selassie, A. W. & Thurman, D. J. (2003). MMWR Surveill. Summ. 52, 1–20. [PubMed]
  14. Langlois, J. A., Rutland-Brown, W. & Thomas, K. E. (2005). J. Head Trauma. Rehabil. 20, 229–238. [DOI] [PubMed]
  15. Love, R. (2005). Lancet Neurol. 4, 458. [DOI] [PubMed]
  16. North, H., Scott, K. R., Stables, J. P. & Wang, X. S. (2012). Abstracts of Papers, 243rd ACS National Meeting & Exposition, San Diego, CA, United States, March 25–29, 2012, COMP-299.
  17. Palatinus, L. & Chapuis, G. (2007). J. Appl. Cryst. 40, 786–790.
  18. Scantlebury, M. H., Gibbs, S. A., Foadjo, B., Lema, P., Psarropoulou, C. & Carmant, L. (2005). Ann. Neurol. 58, 41–49. [DOI] [PubMed]
  19. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) 1, 2, 3. DOI: 10.1107/S1600536814023769/su2795sup1.cif

e-70-00456-sup1.cif (739.5KB, cif)

Structure factors: contains datablock(s) 1. DOI: 10.1107/S1600536814023769/su27951sup2.hkl

e-70-00456-1sup2.hkl (78.3KB, hkl)

Structure factors: contains datablock(s) 2. DOI: 10.1107/S1600536814023769/su27952sup3.hkl

e-70-00456-2sup3.hkl (208.7KB, hkl)

Structure factors: contains datablock(s) 3. DOI: 10.1107/S1600536814023769/su27953sup4.hkl

e-70-00456-3sup4.hkl (228KB, hkl)

Supporting information file. DOI: 10.1107/S1600536814023769/su27951sup5.cml

Supporting information file. DOI: 10.1107/S1600536814023769/su27952sup6.cml

Supporting information file. DOI: 10.1107/S1600536814023769/su27953sup7.cml

CCDC references: 1031391, 1031392, 1031393

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Structure Reports Online are provided here courtesy of International Union of Crystallography

RESOURCES